US Stock MarketDetailed Quotes

ARAY Accuray

Watchlist
  • 2.030
  • +0.110+5.73%
Close Nov 6 16:00 ET
204.15MMarket Cap-11941P/E (TTM)

Accuray Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-176.61%-11.9M
11.27%9.88M
-132.90%-8.1M
71.73%-5.09M
-18,776.09%-8.59M
747.46%15.54M
291.24%8.88M
213.13%24.63M
-155.24%-18.01M
100.53%46K
Net income from continuing operations
-67.51%-15.55M
232.51%3.39M
-1,158.76%-6.34M
-413.39%-9.62M
45.51%-2.97M
-73.56%-9.28M
25.96%-2.56M
157.27%599K
-1,146.93%-1.87M
-430.06%-5.45M
Operating gains losses
193.65%2.27M
139.89%1.14M
313.33%1.43M
-342.64%-1.44M
181.17%1.15M
-178.56%-2.43M
-1,141.24%-2.85M
-47.57%345K
-692.73%-326K
-80.52%409K
Depreciation and amortization
30.44%5.91M
37.37%1.51M
45.15%1.6M
34.32%1.55M
6.38%1.25M
-17.88%4.53M
-13.55%1.1M
-21.38%1.1M
-19.06%1.15M
-17.12%1.18M
Deferred tax
207.46%1.4M
----
----
----
----
-74.45%456K
----
----
----
----
Other non cash items
3.13%955K
2.52%244K
-2.07%236K
3.95%237K
8.68%238K
13.34%926K
6.73%238K
12.09%241K
2.24%228K
40.38%219K
Change In working capital
-574.13%-21.92M
-133.29%-1.85M
-142.77%-8.84M
103.29%711K
-41,300.00%-11.95M
120.46%4.62M
168.36%5.54M
177.91%20.66M
-179.74%-21.61M
100.19%29K
-Change in receivables
-185.60%-15.83M
-3,571.16%-17.7M
-83.22%2.23M
149.56%4.84M
-133.60%-5.2M
247.68%18.49M
93.90%-482K
275.40%13.27M
-180.49%-9.77M
268.51%15.47M
-Change in inventory
41.68%-4M
597.91%18.67M
-270.51%-8.03M
-204.14%-5.72M
27.83%-8.92M
70.01%-6.86M
138.18%2.68M
130.76%4.71M
-221.97%-1.88M
-490.30%-12.36M
-Change in prepaid assets
251.53%6.11M
-12.42%1.68M
191.30%3.16M
1,312.13%3.7M
-11.22%-2.43M
33.32%-4.03M
156.62%1.92M
-93.83%-3.46M
-149.59%-305K
-46.81%-2.18M
-Change in payables and accrued expense
-77.01%859K
-134.38%-2.19M
13.20%2.78M
51.25%-4.54M
13.86%4.81M
-79.65%3.74M
-26.92%6.37M
181.26%2.46M
-181.68%-9.31M
231.66%4.22M
-Change in other current liabilities
199.07%321K
----
----
----
----
63.18%-324K
----
----
----
----
-Change in other working capital
-46.70%-9.38M
42.96%-2.63M
-343.10%-8.97M
790.08%2.44M
95.84%-213K
-576.45%-6.39M
-372.52%-4.61M
103.14%3.69M
-129.32%-353K
-51.91%-5.12M
Cash from discontinued investing activities
Operating cash flow
-176.61%-11.9M
11.27%9.88M
-132.90%-8.1M
71.73%-5.09M
-18,776.09%-8.59M
747.46%15.54M
291.24%8.88M
213.13%24.63M
-155.24%-18.01M
100.53%46K
Investing cash flow
Cash flow from continuing investing activities
71.60%-3.6M
94.17%-465K
58.14%-795K
18.58%-1.25M
14.15%-1.09M
-168.84%-12.68M
-471.35%-7.98M
-78.81%-1.9M
-91.03%-1.53M
12.64%-1.27M
Net PPE purchase and sale
71.45%-3.6M
94.21%-465K
55.98%-795K
16.79%-1.25M
14.15%-1.09M
-167.42%-12.61M
-475.57%-8.04M
-70.06%-1.81M
-86.92%-1.5M
12.64%-1.27M
Net intangibles purchase and sale
--0
--0
--0
----
----
---67K
--0
---34K
----
----
Cash from discontinued investing activities
Investing cash flow
71.60%-3.6M
94.17%-465K
58.14%-795K
18.58%-1.25M
14.15%-1.09M
-168.84%-12.68M
-471.35%-7.98M
-78.81%-1.9M
-91.03%-1.53M
12.64%-1.27M
Financing cash flow
Cash flow from continuing financing activities
-87.07%-3.95M
-32.95%-694K
0.00%-1.5M
-106.01%-257K
65.64%-1.5M
86.26%-2.11M
-470.21%-522K
-50.00%-1.5M
131.64%4.28M
-336.50%-4.37M
Net issuance payments of debt
-55.24%-6M
0.00%-1.5M
0.00%-1.5M
-142.86%-1.5M
65.64%-1.5M
79.66%-3.87M
-50.00%-1.5M
-50.00%-1.5M
121.88%3.5M
-336.50%-4.37M
Net common stock issuance
2.14%2.25M
----
----
----
----
-43.43%2.2M
----
----
----
----
Proceeds from stock option exercised by employees
----
----
--0
----
----
----
----
--0
----
----
Net other financing activities
55.70%-198K
2.41%-81K
--0
----
----
-73.26%-447K
---83K
--0
----
----
Cash from discontinued financing activities
Financing cash flow
-87.07%-3.95M
-32.95%-694K
0.00%-1.5M
-106.01%-257K
65.64%-1.5M
86.26%-2.11M
-470.21%-522K
-50.00%-1.5M
131.64%4.28M
-336.50%-4.37M
Net cash flow
Beginning cash position
1.16%91.2M
-31.59%62.15M
7.63%74.49M
-4.49%78.69M
1.16%91.2M
-23.73%90.15M
-8.50%90.85M
-44.50%69.21M
-22.63%82.39M
-23.73%90.15M
Current changes in cash
-2,708.04%-19.46M
2,177.55%8.72M
-148.98%-10.4M
56.79%-6.6M
-100.02%-11.18M
103.32%746K
106.49%383K
189.08%21.23M
-183.47%-15.27M
49.43%-5.59M
Effect of exchange rate changes
-548.34%-1.35M
-1,464.52%-485K
-571.12%-1.94M
14.61%2.4M
38.89%-1.33M
105.43%302K
99.04%-31K
126.09%412K
2,351.61%2.09M
-232.26%-2.17M
End cash Position
-22.82%70.39M
-22.82%70.39M
-31.59%62.15M
7.63%74.49M
-4.49%78.69M
1.16%91.2M
1.16%91.2M
-8.50%90.85M
-44.50%69.21M
-22.63%82.39M
Free cash flow
-642.51%-15.51M
1,013.12%9.42M
-139.05%-8.9M
67.56%-6.34M
-689.80%-9.68M
140.16%2.86M
114.01%846K
199.81%22.79M
-161.46%-19.55M
87.81%-1.23M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -176.61%-11.9M11.27%9.88M-132.90%-8.1M71.73%-5.09M-18,776.09%-8.59M747.46%15.54M291.24%8.88M213.13%24.63M-155.24%-18.01M100.53%46K
Net income from continuing operations -67.51%-15.55M232.51%3.39M-1,158.76%-6.34M-413.39%-9.62M45.51%-2.97M-73.56%-9.28M25.96%-2.56M157.27%599K-1,146.93%-1.87M-430.06%-5.45M
Operating gains losses 193.65%2.27M139.89%1.14M313.33%1.43M-342.64%-1.44M181.17%1.15M-178.56%-2.43M-1,141.24%-2.85M-47.57%345K-692.73%-326K-80.52%409K
Depreciation and amortization 30.44%5.91M37.37%1.51M45.15%1.6M34.32%1.55M6.38%1.25M-17.88%4.53M-13.55%1.1M-21.38%1.1M-19.06%1.15M-17.12%1.18M
Deferred tax 207.46%1.4M-----------------74.45%456K----------------
Other non cash items 3.13%955K2.52%244K-2.07%236K3.95%237K8.68%238K13.34%926K6.73%238K12.09%241K2.24%228K40.38%219K
Change In working capital -574.13%-21.92M-133.29%-1.85M-142.77%-8.84M103.29%711K-41,300.00%-11.95M120.46%4.62M168.36%5.54M177.91%20.66M-179.74%-21.61M100.19%29K
-Change in receivables -185.60%-15.83M-3,571.16%-17.7M-83.22%2.23M149.56%4.84M-133.60%-5.2M247.68%18.49M93.90%-482K275.40%13.27M-180.49%-9.77M268.51%15.47M
-Change in inventory 41.68%-4M597.91%18.67M-270.51%-8.03M-204.14%-5.72M27.83%-8.92M70.01%-6.86M138.18%2.68M130.76%4.71M-221.97%-1.88M-490.30%-12.36M
-Change in prepaid assets 251.53%6.11M-12.42%1.68M191.30%3.16M1,312.13%3.7M-11.22%-2.43M33.32%-4.03M156.62%1.92M-93.83%-3.46M-149.59%-305K-46.81%-2.18M
-Change in payables and accrued expense -77.01%859K-134.38%-2.19M13.20%2.78M51.25%-4.54M13.86%4.81M-79.65%3.74M-26.92%6.37M181.26%2.46M-181.68%-9.31M231.66%4.22M
-Change in other current liabilities 199.07%321K----------------63.18%-324K----------------
-Change in other working capital -46.70%-9.38M42.96%-2.63M-343.10%-8.97M790.08%2.44M95.84%-213K-576.45%-6.39M-372.52%-4.61M103.14%3.69M-129.32%-353K-51.91%-5.12M
Cash from discontinued investing activities
Operating cash flow -176.61%-11.9M11.27%9.88M-132.90%-8.1M71.73%-5.09M-18,776.09%-8.59M747.46%15.54M291.24%8.88M213.13%24.63M-155.24%-18.01M100.53%46K
Investing cash flow
Cash flow from continuing investing activities 71.60%-3.6M94.17%-465K58.14%-795K18.58%-1.25M14.15%-1.09M-168.84%-12.68M-471.35%-7.98M-78.81%-1.9M-91.03%-1.53M12.64%-1.27M
Net PPE purchase and sale 71.45%-3.6M94.21%-465K55.98%-795K16.79%-1.25M14.15%-1.09M-167.42%-12.61M-475.57%-8.04M-70.06%-1.81M-86.92%-1.5M12.64%-1.27M
Net intangibles purchase and sale --0--0--0-----------67K--0---34K--------
Cash from discontinued investing activities
Investing cash flow 71.60%-3.6M94.17%-465K58.14%-795K18.58%-1.25M14.15%-1.09M-168.84%-12.68M-471.35%-7.98M-78.81%-1.9M-91.03%-1.53M12.64%-1.27M
Financing cash flow
Cash flow from continuing financing activities -87.07%-3.95M-32.95%-694K0.00%-1.5M-106.01%-257K65.64%-1.5M86.26%-2.11M-470.21%-522K-50.00%-1.5M131.64%4.28M-336.50%-4.37M
Net issuance payments of debt -55.24%-6M0.00%-1.5M0.00%-1.5M-142.86%-1.5M65.64%-1.5M79.66%-3.87M-50.00%-1.5M-50.00%-1.5M121.88%3.5M-336.50%-4.37M
Net common stock issuance 2.14%2.25M-----------------43.43%2.2M----------------
Proceeds from stock option exercised by employees ----------0------------------0--------
Net other financing activities 55.70%-198K2.41%-81K--0---------73.26%-447K---83K--0--------
Cash from discontinued financing activities
Financing cash flow -87.07%-3.95M-32.95%-694K0.00%-1.5M-106.01%-257K65.64%-1.5M86.26%-2.11M-470.21%-522K-50.00%-1.5M131.64%4.28M-336.50%-4.37M
Net cash flow
Beginning cash position 1.16%91.2M-31.59%62.15M7.63%74.49M-4.49%78.69M1.16%91.2M-23.73%90.15M-8.50%90.85M-44.50%69.21M-22.63%82.39M-23.73%90.15M
Current changes in cash -2,708.04%-19.46M2,177.55%8.72M-148.98%-10.4M56.79%-6.6M-100.02%-11.18M103.32%746K106.49%383K189.08%21.23M-183.47%-15.27M49.43%-5.59M
Effect of exchange rate changes -548.34%-1.35M-1,464.52%-485K-571.12%-1.94M14.61%2.4M38.89%-1.33M105.43%302K99.04%-31K126.09%412K2,351.61%2.09M-232.26%-2.17M
End cash Position -22.82%70.39M-22.82%70.39M-31.59%62.15M7.63%74.49M-4.49%78.69M1.16%91.2M1.16%91.2M-8.50%90.85M-44.50%69.21M-22.63%82.39M
Free cash flow -642.51%-15.51M1,013.12%9.42M-139.05%-8.9M67.56%-6.34M-689.80%-9.68M140.16%2.86M114.01%846K199.81%22.79M-161.46%-19.55M87.81%-1.23M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Cancer Research
Cancer Research
Intraday-1.53%